A citation-based method for searching scientific literature

Fei Gao, Xiaojing Ma, Jiahui Peng, Jingyi Lu, Wei Lu, Wei Zhu, Yuqian Bao, Robert A Vigersky, Weiping Jia, Jian Zhou. Diabetes Technol Ther 2020
Times Cited: 3







List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
618
66

International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
599
66


Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care.
Sanjay Kalra, Leszek Czupryniak, Gary Kilov, Roberta Lamptey, Ajay Kumar, A G Unnikrishnan, Aissa Boudiba, Mohamed Abid, Zhanay A Akanov, Ali Latheef,[...]. Diabetes Ther 2018
7
33

Fixed-ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin.
Tina Vilsbøll, Thomas C Blevins, Esteban Jodar, Neil Poulter, Nikolaos Tentolouris, Bue F Ross Agner, Lucine Lehmann, Lawrence A Leiter. Diabetes Obes Metab 2019
9
33

Comparison of a soluble co-formulation of insulin degludec/insulin aspart vs biphasic insulin aspart 30 in type 2 diabetes: a randomised trial.
Leo Niskanen, Lawrence A Leiter, Edward Franek, Jianping Weng, Taner Damci, Manuel Muñoz-Torres, Jean-Paul Donnet, Lars Endahl, Trine Vang Skjøth, Allan Vaag. Eur J Endocrinol 2012
38
33

Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetologia 2018
496
33





Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.
Philip Raskin, Elsie Allen, Priscilla Hollander, Andrew Lewin, Robert A Gabbay, Peter Hu, Bruce Bode, Alan Garber. Diabetes Care 2005
417
33


IDegLira Improves Glycemic Control in Japanese Patients with Uncontrolled Type 2 Diabetes on Premixed Insulin Therapy.
Hirotaka Watada, Bue F Ross Agner, Ankur Doshi, Lars Bardtrum, Mattis Flyvholm Ranthe, Liana K Billings. Diabetes Ther 2020
2
50

Switch to Combined GLP1 Receptor Agonist Lixisenatide with Basal Insulin Glargine in Poorly Controlled T2DM Patients with Premixed Insulin Therapy: A Clinical Observation and Pilot Study in Nine Patients.
Jürgen Harreiter, Lana Kosi-Trebotic, Albert Lukas, Peter Wolf, Yvonne Winhofer, Anton Luger, Alexandra Kautzky-Willer, Michael R Krebs. Diabetes Ther 2017
1
100

Supramolecular insulin assembly II for a sustained treatment of type 1 diabetes mellitus.
Sarika Gupta, Tandrika Chattopadhyay, Mahendra Pal Singh, Avadhesha Surolia. Proc Natl Acad Sci U S A 2010
33
33

Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT.
Krzysztof Strojek, Wan M W Bebakar, Duma T Khutsoane, Milica Pesic, Alena Smahelová, Henrik F Thomsen, Sanjay Kalra. Curr Med Res Opin 2009
61
33

The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial.
Sultan Linjawi, Bruce W Bode, Louis B Chaykin, Jean-Pierre Courrèges, Yehuda Handelsman, Lucine M Lehmann, Abhishek Mishra, Richard W Simpson. Diabetes Ther 2017
63
33


Factors Determining the Success of Therapeutic Lifestyle Interventions in Diabetes - Role of Partner and Family Support.
Lovely Gupta, Deepak Khandelwal, Priti Rishi Lal, Yasheep Gupta, Sanjay Kalra, Deep Dutta. Eur Endocrinol 2019
12
33

Clinical inertia in basal insulin-treated patients with type 2 diabetes - Results from a retrospective database study in Japan (JDDM 43).
Jo Satoh, Marc Andersen, Brian Bekker Hansen, Brian Larsen Thorsted, Deniz Tutkunkardas, Mette Zacho, Hiroshi Maegawa. PLoS One 2018
10
33

Rising Costs of Drug/Insulin Treatment for Diabetes: A Perspective from India.
Anoop Misra, Rupali Mukherjee, Atul Luthra, Padam Singh. Diabetes Technol Ther 2017
5
33

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY.
Alan J Garber, Martin J Abrahamson, Joshua I Barzilay, Lawrence Blonde, Zachary T Bloomgarden, Michael A Bush, Samuel Dagogo-Jack, Ralph A DeFronzo, Daniel Einhorn, Vivian A Fonseca,[...]. Endocr Pract 2019
161
33

Evaluation of a Premixed Insulin Analog Suspension in Japanese People with Type 2 Diabetes and the Clinical Importance of Improved Injection Techniques: A Cross-Sectional Pilot Study.
Kunihiro Suzuki, Chie Aoki, Kanako Kato, Masanori Shimizu, Shintaro Sakurai, Kazunori Yanagi, Hisamoto Kuroda, Yoshimasa Aso. Diabetes Ther 2017
1
100



Liraglutide as Adjunct to Insulin Treatment in Patients with Type 1 Diabetes: A Systematic Review and Meta-analysis.
Patoulias Dimitrios, Doumas Michael, Kotsis Vasilios, Stavropoulos Konstantinos, Imprialos Konstantinos, Zografou Ioanna, Petidis Konstantinos, Bakatselos Spyridon, Karagiannis Asterios. Curr Diabetes Rev 2020
12
33

Occurrence and Predictors of Depression and Poor Quality of Life among Patients with Type-2 Diabetes: A Northern India Perspective.
Prerna Bahety, Gunjan Agarwal, Deepak Khandelwal, Deep Dutta, Sanjay Kalra, Pankaj Taparia, Vikas Singhal. Indian J Endocrinol Metab 2017
7
33


Use of 50/50 Premixed Insulin Analogs in Type 2 Diabetes: Systematic Review and Clinical Recommendations.
Gary Deed, Gary Kilov, Trisha Dunning, Richard Cutfield, Jane Overland, Ted Wu. Diabetes Ther 2017
3
33

Premix insulins in type 1 diabetes: the coming of degludec/aspart.
Marc Rendell. Expert Opin Drug Metab Toxicol 2019
1
100


Neck Circumference to Height Ratio is a Reliable Predictor of Liver Stiffness and Nonalcoholic Fatty Liver Disease in Prediabetes.
Samim Ali Mondal, Deep Dutta, Manoj Kumar, Pankaj Singh, Madhurima Basu, Chitra Selvan, Satinath Mukhopadhyay. Indian J Endocrinol Metab 2018
4
33

Comparison of the Effect of Glycemic Control in Type 2 Diabetes Outpatients Treated With Premixed and Basal Insulin Monotherapy in China.
Guangxu Liu, Jingtao Dou, Yuesong Pan, Yuxiang Yan, Huiping Zhu, Juming Lu, Herbert Gaisano, Linong Ji, Yan He. Front Endocrinol (Lausanne) 2018
3
33


Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial.
Vanita R Aroda, Guillermo González-Galvez, Randi Grøn, Natalie Halladin, Martin Haluzík, György Jermendy, Adri Kok, Petra Őrsy, Mohamed Sabbah, Giorgio Sesti,[...]. Lancet Diabetes Endocrinol 2019
15
33


Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical Trial.
Ildiko Lingvay, Federico Pérez Manghi, Pedro García-Hernández, Paul Norwood, Lucine Lehmann, Mads Jeppe Tarp-Johansen, John B Buse. JAMA 2016
114
33






Reference values for continuous glucose monitoring in Chinese subjects.
Jian Zhou, Hong Li, Xingwu Ran, Wenying Yang, Qiang Li, Yongde Peng, Yanbing Li, Xin Gao, Xiaojun Luan, Weiqing Wang,[...]. Diabetes Care 2009
85
33

Glucose Variability Assessed with Continuous Glucose Monitoring: Reliability, Reference Values, and Correlations with Established Glycemic Indices-The Maastricht Study.
Yuri D Foreman, Martijn C G J Brouwers, Carla J H van der Kallen, Demi M E Pagen, Marleen M J van Greevenbroek, Ronald M A Henry, Annemarie Koster, Anke Wesselius, Nicolaas C Schaper, Coen D A Stehouwer. Diabetes Technol Ther 2020
8
33

HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study.
Kasia J Lipska, E Margaret Warton, Elbert S Huang, Howard H Moffet, Silvio E Inzucchi, Harlan M Krumholz, Andrew J Karter. Diabetes Care 2013
144
33

Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials.
Sophia Zoungas, Hisatomi Arima, Hertzel C Gerstein, Rury R Holman, Mark Woodward, Peter Reaven, Rodney A Hayward, Timothy Craven, Ruth L Coleman, John Chalmers. Lancet Diabetes Endocrinol 2017
180
33

Glycaemic variability in diabetes: clinical and therapeutic implications.
Antonio Ceriello, Louis Monnier, David Owens. Lancet Diabetes Endocrinol 2019
133
33

Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring.
Jian Zhou, Hong Li, Xingwu Ran, Wenying Yang, Qiang Li, Yongde Peng, Yanbing Li, Xin Gao, Xiaojun Luan, Weiqing Wang,[...]. Med Sci Monit 2011
52
33



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.